Business Description
Founded in 2003 and based in Israel, BioLineRx is a drug development company focused on cancer and rare diseases. Its leading programs include an oral cancer treatment targeting DNA damage mechanisms in brain tumors and other cancers, a peptide-based therapy being studied across multiple conditions including sickle cell disease and pancreatic cancer, and a non-surgical skin lesion removal product. The company has completed a major late-stage clinical trial for multiple myeloma and continues to advance a broad range of treatments through various stages of development.
